A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways The Institute of Biomedical Science (IBMS) is announcing the findings of an independent report showing that the presence of biomedical scientists in the bowel […]
Read More… from Biomedical Scientists Benefit NHS Up to £571M in Bowel Cancer Care